StockWatch
·
Pharmaceuticals
Board Meeting4 Nov 2026, 02:21 pm

Coral Laboratories Ltd Board Meeting on Nov 14, 2026

AI Summary

Coral Laboratories Ltd has announced that its Board of Directors will convene on November 14, 2026. The primary agenda item is to consider and approve the standalone unaudited financial results for the quarter and half-year ended September 30, 2026. Additionally, the board may discuss other business matters as permitted by the chairman. In accordance with SEBI regulations, the trading window for the company's shares has been closed from October 1, 2026, and will reopen 48 hours after the financial results are declared.

Key Highlights

  • Board meeting scheduled for November 14, 2026.
  • To consider and approve Q2/H1 FY27 unaudited financial results.
  • Trading window closed from October 1, 2026.
  • Trading window to reopen 48 hours post-results declaration.